A Randomized, Controlled, Noninferiority, Multicenter Trial of Systemic vs Intralesional Treatment With Meglumine Antimoniate for Cutaneous Leishmaniasis in Brazil.

MLA

Lyra, Marcelo R., et al. “A Randomized, Controlled, Noninferiority, Multicenter Trial of Systemic vs Intralesional Treatment With Meglumine Antimoniate for Cutaneous Leishmaniasis in Brazil.” Clinical Infectious Diseases, vol. 77, no. 4, Aug. 2023, pp. 574–82. EBSCOhost, https://doi.org/10.1093/cid/ciad253.

APA

Lyra, M. R., Oliveira, L. F. A., Schubach, A. O., Sampaio, R. N. R., Rodrigues, B. C., Hueb, M., Cota, G., Silva, R. E., Francesconi, F., Pompilio, M. A., França, A. O., Amato, V. S., Souza, R. M., Oliveira, R. V. C., Valete, C. M., & Pimentel, M. I. F. (2023). A Randomized, Controlled, Noninferiority, Multicenter Trial of Systemic vs Intralesional Treatment With Meglumine Antimoniate for Cutaneous Leishmaniasis in Brazil. Clinical Infectious Diseases, 77(4), 574–582. https://doi.org/10.1093/cid/ciad253

Chicago

Lyra, Marcelo R, Liliane F A Oliveira, Armando O Schubach, Raimunda N R Sampaio, Bruna C Rodrigues, Marcia Hueb, Gláucia Cota, et al. 2023. “A Randomized, Controlled, Noninferiority, Multicenter Trial of Systemic vs Intralesional Treatment With Meglumine Antimoniate for Cutaneous Leishmaniasis in Brazil.” Clinical Infectious Diseases 77 (4): 574–82. doi:10.1093/cid/ciad253.